Ledipasvir/sofosbuvir for 12 weeks is safe and effective in patients with chronic hepatitis C and hepatitis B coinfection: A phase 3 study in TaiwanC.-J. Liu,W.-L. Chuang,I.-S. Sheen,H.-Y. Wang,C.-Y. Chen,K.-C. Tseng,T.-T. Chang,B. Massetto, J. Yang,G. Camus,F. Zhang,D.M. Brainard,J.G. McHutchison,T.-H. Hu,Y.-C. Hsu,G.-H. Lo,C.-J. Chu, J.-J. Chen,C.-Y. Peng,R.-N. ChienJournal of Hepatology（2017）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
